1. Home
  2. SLAB vs RYTM Comparison

SLAB vs RYTM Comparison

Compare SLAB & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Laboratories Inc.

SLAB

Silicon Laboratories Inc.

HOLD

Current Price

$218.01

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$107.03

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLAB
RYTM
Founded
1996
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
5.8B
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
SLAB
RYTM
Price
$218.01
$107.03
Analyst Decision
Hold
Strong Buy
Analyst Count
11
14
Target Price
$163.13
$131.14
AVG Volume (30 Days)
345.6K
765.9K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
66.61
28.34
EPS
N/A
N/A
Revenue
$491,625,000.00
N/A
Revenue This Year
$20.49
$55.34
Revenue Next Year
$16.65
$86.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.51
$62.29
52 Week High
$220.90
$122.20

Technical Indicators

Market Signals
Indicator
SLAB
RYTM
Relative Strength Index (RSI) 49.36 74.97
Support Level $217.03 $97.65
Resistance Level $219.18 $113.03
Average True Range (ATR) 1.58 4.92
MACD -0.22 2.17
Stochastic Oscillator 24.58 84.20

Price Performance

Historical Comparison
SLAB
RYTM

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: